Allergan Shows Off Phase III Migraine Data Post author:Sam Post published:February 5, 2018 Post category:BioPharma The ACHIEVE I study included 1327 U.S. adult patients. Source: BioSpace You Might Also Like Medivir's Nomination Committee Proposes New Board Of Directors Ahead Of 2017 AGM February 23, 2017 These 2 Startups are Amgen's 2017 Golden Ticket Winners December 14, 2017 Watch Out: Cambridge Biotech Makes a Comeback January 16, 2018
